[Form 3] InspireMD, Inc. Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

InspireMD's new Chief Financial Officer Michael Lawless filed an initial Form 3 statement disclosing his beneficial ownership position upon appointment. The filing reveals two key components of his compensation package:

• 465,000 restricted stock shares vesting in three equal annual installments of 155,000 shares each on June 25, 2026, 2027, and 2028
• 212,000 stock options with an exercise price of $2.24, vesting similarly in three equal annual installments through 2028

All equity awards are contingent on Lawless's continued service with the company. This initial beneficial ownership disclosure, filed within the required timeline following his appointment, demonstrates a significant equity-based compensation structure aligned with long-term shareholder interests through the extended vesting schedule.

Positive

• New CFO Michael Lawless granted significant equity stake with 465,000 restricted shares and 212,000 stock options, aligning management interests with shareholders
• Long-term vesting schedule over 3 years (2026-2028) encourages retention and long-term value creation

Negative

• None.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lawless Michael A

(Last) (First) (Middle)

C/O INSPIREMD, INC.

6303 WATERFORD DISTRICT DRIVE, SUITE 215

(Street)

MIAMI FL 33126

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
06/25/2025

3. Issuer Name and Ticker or Trading Symbol
InspireMD, Inc. [ NSPR ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	465,000(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options to purchase common stock (right to buy)	(2)	06/25/2035	Common Stock	212,000	$2.24	D

Explanation of Responses:

1. These shares of common stock represent 465,000 shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of June 25, 2026, June 25, 2027 and June 25, 2028, subject to the Reporting Person's continued service.

2. The options vest and become exercisable in three equal installments, with 1/3 vesting on each of June 25, 2026, June 25, 2027 and June 25, 2028, subject to the Reporting Person's continued service.

Remarks:

Exhibit 24.1: Power of Attorney

	/s/ Michael Lawless	06/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who is NSPR's new Chief Financial Officer appointed in June 2025?

Michael A. Lawless was appointed as InspireMD's (NSPR) Chief Financial Officer, as disclosed in a Form 3 filing dated June 28, 2025.

How many shares of NSPR restricted stock does Michael Lawless own?

Michael Lawless owns 465,000 shares of restricted stock, which vest in three equal annual installments of 1/3 each on June 25, 2026, June 25, 2027, and June 25, 2028, subject to his continued service.

What stock options were granted to NSPR's new CFO Michael Lawless?

Michael Lawless was granted options to purchase 212,000 shares of common stock at an exercise price of $2.24. The options vest in three equal annual installments on June 25, 2026, June 25, 2027, and June 25, 2028, subject to continued service.

When do Michael Lawless's NSPR stock options expire?

Michael Lawless's stock options expire on June 25, 2035, ten years after the grant date.

What is the vesting schedule for NSPR CFO Michael Lawless's equity compensation?

Both Michael Lawless's 465,000 restricted shares and 212,000 stock options vest in three equal annual installments, with 1/3 vesting on each of June 25, 2026, June 25, 2027, and June 25, 2028, contingent upon his continued service with the company.